Achieve Life Sciences submitted a New Drug Application to the FDA regarding the smoking health epidemic in the US.

2 reports, 1 independent Updated Jul 29

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Achieve Life Sciences submitted a New Drug Application to the FDA regarding the smoking health epidemic in the US.

Who's involved

What this event is mainly about

Achieve Life Sciences (United States)FDA

Keep exploring

Part of

The FDA proposed a new standard to curb nicotine addiction in tobacco products, prompting industry changes. All 2 developments

The entities involved

Achieve Life Sciences (United States)
organization

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

Coverage

Newest first; wire copies grouped

Jul 29GlobeNewswireAchieve Life Sciences to Participate in the BTIG Virtual Biotechnology Conference SEATTLE and VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV)
Jul 24GlobeNewswireAchieve Life Sciences to Announce Second Quarter Financial Results and Host Conference Call and Webcast on August 7, 2025 SEATTLE and VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Ac